The Italian army has grown its first successful crop of marijuana
It aims to grow 100kg of the drug annually
Your support helps us to tell the story
As your White House correspondent, I ask the tough questions and seek the answers that matter.
Your support enables me to be in the room, pressing for transparency and accountability. Without your contributions, we wouldn't have the resources to challenge those in power.
Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election
Andrew Feinberg
White House Correspondent
The Italian army has unveiled its first cannabis farm, which has been established to drive down the cost of medical marijuana in the country.
The government announced the initiative back in September, which will see the army producing 100kg of the drug every year.
It opened the doors to its secure growing room in a military-run pharmaceutical plant in Florence for the first time this week, with its crop flourishing.
"The aim of this operation is to make available to a growing number of patients a medical product which isn't always readily available on the market, at a much better price for the user," Colonel Antonio Medica told Corriere della Sera.
Doctors can legally prescribe marijuana in Italy, but many patients couldn't afford their prescription as the cost of the drug was not covered by the state.
Until now, marijuana was being imported from the Netherlands and costed patients up to 35 euros a gram.
"We're aiming to lower the price to under 15 euros, maybe even around 5 euros per gram," Medica said.
The army facility, where other drugs are produced for the military, was chosen due to its high security and surveillance system.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments